000915 Shandong Wit Dyne Health
- 32.31
- -0.41-1.25%
Shandong Wit Dyne Health News
Guohai Securities released a research report on April 21 stating that it gave Walter Dyne (000915.SZ) a purchase rating. The main reasons for the rating include: 1) strong R&D strength, focusing on the field of child health; 2) intelligent upgrading promo
Walter Dyne (000915): Continued development of new products, steady growth in performance
Walter Dyne (000915) 2023 Annual Report Review Report: Rich Product Layout, Steady Performance Growth
Walter Dyne (000915): Optimistic about high dividends, new volume, and steady growth
Walter Dyne (000915) 2023 Annual Report Review: Focus on the steady growth of the main business and significantly increase the dividend ratio
Walter Dyne (000915): Steady growth of Dyne Pharmaceutical continues to focus on the main pharmaceutical industry
Walter Dyne (000915): Dyne Pharmaceutical's revenue grew steadily, short-term profit fluctuations did not change long-term growth
Walter Dyne (000915): Stable performance in the third quarter and expects energy storage to accelerate
Walter Dyne (000915): The main business had a good growth trend in the first half of the year, causing disturbances in non-main businesses
Walter Dyne (000915): Non-main business dragged down apparent growth in the first quarter, and main business performance was steady
Walter Dyne (000915): Outstanding performance growth in 2022, focusing on the continued development of the main business
Walter Dyne (000915): Performance is in line with expectations and optimistic about future growth
Walter Dyne (000915): Continued focus on steady performance growth in the pharmaceutical industry in 2022
Walter Dyne (000915): Dyne Pharmaceutical grew strongly throughout the year, and the momentum for state-owned enterprise reform remained unabated
Walter Dyne (000915): Performance is in line with expectations and is optimistic about subsequent development
Walter Dyne (000915): Ike's volume and price soared, and its performance in the third quarter was impressive
Walter Dyne (000915): Vitamin AD leader's profit continues to grow at a high rate
Walter Dyne (000915): The company's performance exceeded expectations, and the profitability of the pharmaceutical industry increased
Walter Dyne (000915): Performance exceeded expectations in the third quarter, and Dyne Pharmaceuticals achieved high growth
Walter Dyne (000915): Major products continued to rise, and performance grew steadily in the third quarter
Analysis
Price Target
No Data
